Scientific INformAtion for Policy Support in Europe
Sinapse home page

Library of scientific opinion & advice > Document description

Should you like to save, print or communicate the information related to this document, you can download this description page in a word processor compatible format.

DOCUMENT GENERAL INFORMATION

TITLE Cancers. Long-term prognoses   synthese_en_cancer.pdf (214.1 KB)
Title in the original language Cancers. Pronostic à long terme  synthese_fr_cancer.pdf (678.1 KB)
Document ID LIB528
Document type Scientific experts report/advice
Issue date 19/04/2006
Document reference ISBN 2-85598-848-9
Original language of the document French
Full text available in EN (214.1 KB) and FR (678.1 KB)
Document produced by National Health and Medical Research Institute organisation visiting card
Department/Service/Committee: Inserm Collective Expertise Center
Document requested by French Authority General of Health, French National Cancer Institute
Document uploaded by VERONIQUE LEGRAND
National Health and Medical Research Institute
(05/09/2007)
Scientific domains
Policy domains
  • Health
  • Science and Research

DOCUMENT TEXT

Short description  The access to insurance of patients having undergone cancer treatment is a subject that concerns both patients and public authorities. The difficulties encountered in this area by patients and former patients impact their social and professional lives.
In order to determine the “additional premiums for increased risks”, our knowledge of the life expectancies of patients treated for cancer at a given time was reviewed taking account the main parameters with an impact on life expectancy (age, gender, cancer stage, therapeutic progress, etc.).The provision of recent and validated life expectancy data for the various disease sites should enabled enhanced scientific pertinence with respect to the modalities of premium determination.

Short description in the original language  L’accès aux assurances des personnes traitées pour un cancer est un sujet qui préoccupe les malades et les pouvoirs publics. Les difficultés rencontrées dans ce domaine, par les patients et les anciens patients, affectent leur vie sociale et professionnelle.
Pour aider à déterminer les « surprimes pour risques aggravés », une mise à jour des connaissances sur l’espérance de vie des patients soignés à un moment donné pour un cancer a été effectuée, en prenant en compte les principaux paramètres ayant un impact sur celle-ci (âge, sexe, stade du cancer, évolution des thérapeutiques…). La mise à disposition de données récentes et validées de durée de vie pour les différentes localisations de cancer permet d’offrir une meilleure pertinence scientifique aux modalités de tarification.

Full Text

PAGE LOADING
Please wait...
Sinapse is currently processing your request.

This might take a few moments before the page can be displayed.
loading